The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.
暂无分享,去创建一个
P. Harris | J. Cheadle | A. C. Jones | J. Sampson | J R Sampson | A C Jones | J P Cheadle | P C Harris | J. Myring | A. Fryer | M M Maheshwar | J Myring | A E Fryer | M. Maheshwar | A. Jones | J. R. Sampson | A. E. Fryer | Jenny Myring | Peter C. Harris
[1] J. Declue,et al. Identification of Tuberin, the Tuberous Sclerosis-2 Product. TUBERIN POSSESSES SPECIFIC Rap1GAP ACTIVITY (*) , 1995, The Journal of Biological Chemistry.
[2] K. S. Fuiks,et al. Tuberous sclerosis (2nd ed.) , 1989 .
[3] S. Smalley,et al. Phenotypic variation of tuberous sclerosis in a single extended kindred. , 1994, Journal of medical genetics.
[4] S. Verhoef,et al. Identification of a nonsense mutation at the 5' end of the TSC2 gene in a family with a presumptive diagnosis of tuberous sclerosis complex. , 1996, Journal of medical genetics.
[5] M. Pericak-Vance,et al. A novel splice site mutation (156 + 1G→A) in the TSC2 gene , 1997, Human mutation.
[6] M. Short,et al. Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients. , 1996, Human molecular genetics.
[7] J. Attwood,et al. Two loci for Tuberous Sclerosis: one on 9q34 and one on 16p13 , 1994, Annals of human genetics.
[8] F. McCormick,et al. Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21 rap1 , 1991, Cell.
[9] M. Delgado,et al. Mutations and polymorphisms in the tuberous sclerosis complex gene on chromosome 16 , 1997, Human mutation.
[10] D. Lipman,et al. Improved tools for biological sequence comparison. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Sandford,et al. Comparative analysis and genomic structure of the tuberous sclerosis 2 (TSC2) gene in human and pufferfish. , 1996, Human Molecular Genetics.
[12] M. Lerman,et al. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. , 1994, Human molecular genetics.
[13] E. Golemis,et al. The Tuberous Sclerosis 2 Gene Product, Tuberin, Functions as a Rab5 GTPase Activating Protein (GAP) in Modulating Endocytosis* , 1997, The Journal of Biological Chemistry.
[14] J. Hughes,et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease — a contiguous gene syndrome , 1994, Nature Genetics.
[15] Mark S. Boguski,et al. Proteins regulating Ras and its relatives , 1993, Nature.
[16] B. Scheithauer,et al. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. , 1996, American journal of human genetics.
[17] M. Pericak-Vance,et al. A de novo frame-shift mutation in the tuberin gene. , 1995, Human molecular genetics.
[18] S. Thomas,et al. Identification and characterization of the tuberous sclerosis gene on chromosome 16 , 1993, Cell.
[19] T. Sepp,et al. Loss of heterozygosity in tuberous sclerosis hamartomas. , 1996, Journal of medical genetics.
[20] A. Ouweland,et al. Somatic mosaicism and clinical variation in tuberous sclerosis complex , 1995, The Lancet.
[21] A. Green,et al. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients , 1994, Nature Genetics.
[22] D. Kwiatkowski,et al. Tuberous sclerosis. , 1994, Archives of dermatology.
[23] J B Stephenson,et al. Genetic aspects of tuberous sclerosis in the west of Scotland. , 1989, Journal of medical genetics.
[24] P. Huttenlocher,et al. Report of the Diagnostic Criteria Committee of the National Tuberous Sclerosis Association , 1992 .
[25] T. Kobayashi,et al. cDNA structure, alternative splicing and exon-intron organization of the predisposing tuberous sclerosis (Tsc2) gene of the Eker rat model. , 1995, Nucleic acids research.